Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 14/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 9/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CCL5 | P13501 | 6/20 | 0.47 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.41 |
| ▸ | CCR3 | P51677 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2766400 | 0.91 | CCR5 (0.56) | CCR5KCNH2CYP3A4CYP2D6CCL5 | |
| SCHEMBL4907587 | 0.89 | CCR5 (0.55) | CCR5KCNH2CYP3A4CYP2D6CCL5 | |
| SCHEMBL4910132 | 0.88 | CCR5 (0.57) | CCR5KCNH2CYP3A4CYP2D6CCL5 | |
| SCHEMBL3595208 | 0.86 | CCR5 (0.61) | CCR5KCNH2CYP3A4CYP2D6CCL5 | |
| SCHEMBL13376794 | 0.85 | CCR5 (0.55) | CCR5KCNH2CYP3A4CYP2D6CCL5 | |
| SCHEMBL4912503 | 0.85 | CCR5 (0.57) | CCR5KCNH2CYP3A4CYP2D6CCL5 | |
| SCHEMBL5499196 | 0.84 | CCR5 (0.57) | CCR5KCNH2CYP3A4CYP2D6CCL5 | |
| SCHEMBL5221963 | 0.84 | CCR5 (0.57) | CCR5KCNH2CYP3A4CYP2D6CCL5 | |
| SCHEMBL5217699 | 0.82 | CCR5 (0.56) | CCR5KCNH2CYP3A4CYP2D6CCL5 | |
| SCHEMBL4915433 | 0.81 | CCR5 (0.65) | CCR5KCNH2CYP3A4CYP2D6CCL5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080200460-A1 | Chemical Compounds | BROWN DEARG | 2008-08-21 | — | — | US | disclosed |
| US-20080200460-A1 | Chemical Compounds | BROWN DEARG | 2008-08-21 | — | — | US | disclosed |
| US-20080200460-A1 | Chemical Compounds | BROWN DEARG | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200460-A1 | Chemical Compounds | CCR5, CXCR4, CXCR5 | CCR5 1/4885KCNH2 2817/4885CYP3A4 418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.